These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 20886177)
1. Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling. Colman RW; Wu Y; Liu Y Thromb Haemost; 2010 Nov; 104(5):875-85. PubMed ID: 20886177 [TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization. Liu Y; Cao DJ; Sainz IM; Guo YL; Colman RW Am J Physiol Cell Physiol; 2008 Jul; 295(1):C257-67. PubMed ID: 18495808 [TBL] [Abstract][Full Text] [Related]
4. Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway. Liu Y; Pixley R; Fusaro M; Godoy G; Kim E; Bromberg ME; Colman RW Oncogene; 2009 Jul; 28(30):2756-65. PubMed ID: 19483730 [TBL] [Abstract][Full Text] [Related]
5. VEGF-initiated angiogenesis and the uPA/uPAR system. Breuss JM; Uhrin P Cell Adh Migr; 2012; 6(6):535-615. PubMed ID: 23076133 [TBL] [Abstract][Full Text] [Related]
6. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Xue A; Xue M; Jackson C; Smith RC Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314 [TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells. Cao DJ; Guo YL; Colman RW Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324 [TBL] [Abstract][Full Text] [Related]
9. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer. Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104 [TBL] [Abstract][Full Text] [Related]
11. Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines. Raghu H; Lakka SS; Gondi CS; Mohanam S; Dinh DH; Gujrati M; Rao JS PLoS One; 2010 Aug; 5(8):e12458. PubMed ID: 20805979 [TBL] [Abstract][Full Text] [Related]
12. The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases. Liu Y; Sainz IM; Wu Y; Pixley R; Espinola RG; Hassan S; Khan MM; Colman RW Exp Cell Res; 2008 Feb; 314(4):774-88. PubMed ID: 18062965 [TBL] [Abstract][Full Text] [Related]
13. uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells. Raghu H; Nalla AK; Gondi CS; Gujrati M; Dinh DH; Rao JS Mol Oncol; 2012 Feb; 6(1):33-47. PubMed ID: 22177802 [TBL] [Abstract][Full Text] [Related]
14. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849 [TBL] [Abstract][Full Text] [Related]
15. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356 [TBL] [Abstract][Full Text] [Related]